CML cells express the oncogenic p210 BCR-ABL fusion protein, a constitutively active tyrosine kinase that stimulates multiple growth promoting signalling pathways. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.